Compare BBIO & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBIO | JZXN |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 16.2M |
| IPO Year | 2019 | 2021 |
| Metric | BBIO | JZXN |
|---|---|---|
| Price | $75.29 | $1.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $76.24 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 841.3K |
| Earning Date | 10-29-2025 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $353,780,000.00 | $97,465.00 |
| Revenue This Year | $127.64 | N/A |
| Revenue Next Year | $78.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 62.46 | N/A |
| 52 Week Low | $27.23 | $1.58 |
| 52 Week High | $78.44 | $312.80 |
| Indicator | BBIO | JZXN |
|---|---|---|
| Relative Strength Index (RSI) | 60.10 | 53.31 |
| Support Level | $75.82 | $1.58 |
| Resistance Level | $77.48 | $2.09 |
| Average True Range (ATR) | 2.20 | 0.87 |
| MACD | -0.34 | -0.06 |
| Stochastic Oscillator | 61.00 | 18.87 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.